openPR Logo
Press release

Intraocular Melanoma Treatment Market Entry Strategies, Regulatory Framework, Global Trends, Next-Generation Products Analysis Till 2026 Astra Zeneca plc, Eli Lilly & Co., Pfizer, Inc. Novartis AG, and Spectrum Pharmaceuticals, Inc.

01-25-2019 08:56 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Global Intraocular Melanoma Treatment Market

Global Intraocular Melanoma Treatment Market

Intraocular (uveal) melanoma is a rare eye cancer, characterized with blurred vision or a dark spot on the iris. Various treatment options are available for intraocular melanoma, such as eye examinations. According to the National Cancer Institute (NCI), the standard treatments include surgery, radiation therapy, photocoagulation, and thermotherapy. Along with these standard treatments, some other treatments are also being tested in clinical trials. For instance, Nivolumab: an immunotherapy drugs shown to help people suffering from uveal melanoma by increasing patient’s overall immunity, are presently in Phase II clinical study. Additionally, other similar drugs being studied for uveal melanoma include combination of Ipilimumab and Nivolumab, and Selumetinib. Selumetinib is a targeted drug known to slow down the growth of eye melanoma, while nivolumab in combination with lpilimumab are being studied to control uveal melanoma are present in Phase II clinical study.

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/1854

According to American Society of Clinical Oncology (ASCO), individuals belonging to Caucasian race, people with light eye color and fair skin, or any individual and any of their family member having history of suffering from dysplastic nevus syndrome, seem to have a higher risk of developing intraocular melanoma. Moreover, over-exposure to sunlight, a known risk factor for melanoma of the skin, is also a risk factor for intraocular melanoma. These factors in turn, are expected to boost growth of the intraocular melanoma treatment market in the near future.

Intraocular Melanoma Treatment Market Drivers:

Advancements in developing innovative treatment options in intraocular melanoma treatments such as understanding the molecular characteristics of intraocular tumor through genetic alternations and mutations studies in patients and novel therapies based on inhibition mechanism of expression of growth factor receptors such as c-Met and c-Kit, are being investigated to bring better treatment options for patients.

Moreover, rampant research pertaining to melanoma, increasing incidence burden of intraocular melanoma, and increasing number of clinical trials for new treatments, in turn, are expected to boost growth of the intraocular melanoma treatment market size over the forecasted period. For instance, according to the American Society of Clinical Oncology (ASCO), in 2015, around 3,540 adults (2,130 men and 1,410 women) in the U.S. were diagnosed with primary intraocular cancer. According to the American Academy of Ophthalmology (AAO), 2014 data findings, uveal melanoma is the most commonly diagnosed primary intraocular malignancy in adults, with 90% of uveal melanoma involving the choroid, 5% affecting the ciliary body, and 5% developing in the iris. Additionally, uveal melanoma accounts for 5%-10% of all melanomas. Additionally, according to the American Academy of Ophthalmology (AAO), 2014 data findings, incidence of intraocular melanoma is higher among the fairly pigmented groups while exceedingly lower among Asian and African population.

Intraocular Melanoma Treatment Market – Regional Analysis:

Geographically, the global intraocular melanoma treatment market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America accounted for the major market share in 2017 and is expected to show lucrative growth opportunities in the near future, owing to increasing engagement of various government and private organizations in developing effective treatment options and rising incidence of intraocular melanoma in the region. For instance, according to the National Cancer Institute (NCI) data in 2016, the mean age-adjusted incidence of uveal melanoma in the U.S. is around 4.3-8.4 new cases per million people per year.

Several research organizations, in the regions are engaged in raising funding for research to develop intraocular melanoma treatment options. For instance, Melanoma Research Foundation (MRF), a Washington-based organization committed to develop effective treatment in various types of melanoma, raised around US$ 1.2 million for ocular melanoma and its treatment, since 2012. Furthermore, in April 2018, the Ocular Melanoma Foundation (OMF), in collaboration with the American Association for Cancer Research (AACR), offered research funding of US$ 150,000 to researchers at the Casey Eye Institute, to study circulating hybrid tumor cells as a prognostic biomarker for ocular melanoma.

To Get More Information about this Market: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1854

Intraocular Melanoma Treatment Market Taxonomy:

By Treatment
• Targeted Therapy
◦ Rituximab (Rituxan)
◦ Ibritumomab (Zevalin)
◦ Imatinib (Gleevec)
◦ Sorafenib (Nexavar)
• Other Therapies

By End User:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Intraocular Melanoma Treatment Market Competitive Landscape:

Some of the key players operating in the intraocular melanoma market are Astra Zeneca plc, Eli Lilly & Co., Pfizer, Inc. Novartis AG, and Spectrum Pharmaceuticals, Inc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intraocular Melanoma Treatment Market Entry Strategies, Regulatory Framework, Global Trends, Next-Generation Products Analysis Till 2026 Astra Zeneca plc, Eli Lilly & Co., Pfizer, Inc. Novartis AG, and Spectrum Pharmaceuticals, Inc. here

News-ID: 1532687 • Views: 891

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Melanoma

Global Melanoma Drugs Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the
Global Drugs for Melanoma Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic
Europe and Israel Mobile Applications for Melanoma Detection Market: Rising prev …
According to the TMR report, the Europe mobile applications for melanoma detection market could collect a larger revenue of around US$1.5 mn by the end of 2022. Even though Greece is dealing with economic volatility, it has been prognosticated to exhibit a perpetually elevating growth until the same year. Rise in Mortality Rate and Melanoma Incidence Puts Heavy Influence on Early Diagnosis Europe and Israel mobile applications for melanoma detection market has
Melanoma Treatment Market – Global Industry Insights, 2025
Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Malignant Melanoma 2. Malignant Melanoma Drug Mechanism of Action 3. Global Malignant Melanoma Market Analysis 3.1 Current Market Scenario 3.2 Global Malignant Melanoma Pipeline Overview 4. Global Malignant Melanoma Drug Market Dynamics 4.1 Favorable Market Parameters 4.2 Commercialization Challenges 5. Global Malignant Melanoma Drug Market Future Prospects 6. Global Malignant Melanoma Clinical Pipeline By